治療癌因性疲憊之新藥介紹－黃耆多醣

Introduction of New Drugs for Cancer-Related Fatigue-Astragalus Polysaccharides

鄭曉倩(Hsiao-Chien Cheng)

《腫瘤護理雜誌》 13卷2期 (2013/12) Pp. 33-37

https://doi.org/10.6880/TJON.201312_13(2).04

摘要

癌因性疲憊（cancer-related fatigue，CRF）是癌症治療範疇中，極易被忽略的症狀，屬國際疾病分類ICD-10-CM明確定義的疾病。美國國家癌症資訊網（National Comprehensive Cancer Network，NCCN）所提出癌因性疲憊指引中說明，改善「癌因性疲憊」的方式有非藥物治療與藥物治療兩大類，在藥物治療方面，目前台灣衛生福利部食品藥物管理署核准的「黃耆多醣注射劑」是一種由醫藥中補氣益虛之上藥黃耆（Astragalus Membranaceus），經由萃取分離以及純化而成之黃耆多醣（Astragalus Polysaccharides），具雙向免疫調節作用，同時能增強使用者的免疫力，尤其以疲勞症狀的改善效果最為顯著，能有效改善癌症病患的生活品質。

關鍵字

癌症 ； 癌因性疲憊 ； 黃耆多醣

並列摘要

Cancer-related fatigue (CRF) is commonly experienced by cancer patients. However CRF is often disregarded by healthcare professionals. The International Classification of Diseases (ICD-10-CM) has clearly defined the disease in 1998. The National Comprehensive Cancer Network (NCCN) had set up the guidelines for the management of cancer-related fatigue, including non-pharmacological and pharmacological interventions. The injection of astragalus polysaccharides approved by Taiwan Food and Drug Administration, is a specific fraction of polysaccharides isolated from the radix of astragalus membranaceus, a commonly used herbal component in traditional Chinese medicine. Astragalus polysaccharides injection is a bidirectional immunomodulatory agent that can enhance the patient's immune function, most of all, it can improve cancer-related fatigue and maintain the patients' quality of life in a better condition.

並列關鍵字

cancer ； cancer-related fatigue ； astragalus polysaccharides